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10.1 INTRODUCTION
Tendons are unique connective tissues with the vital role to store and return elastic 
energy, resist damage, provide mechanical feedback and amplify or attenuate muscle 
power, and transmit forces from muscle to bone. Although tendon relevance in joint 
biomechanics and overall human body is often misunderstood and disregarded to 
other tissues, such as bone or cartilage, recent growing interest in tendon mechanical 
properties has highlighted potential studies working towards improved therapeutic 
strategies in the orthopedic !eld.
The term “tendon” comes from the Latin word, tendere, meaning to stretch (Liu 
et al. 2011). Despite the high tensile strength, tendons have limited intrinsic healing 
capabilities. It is estimated that approximately 50% of all musculoskeletal injuries 
are tendon-related (Praemer et al. 1992). Upon injury, the tendon undergoes degener-
ation and morphohistological misalignment of the collagen !bers. Ultimately, severe 
damage will result in pain and disability. Thus, a major challenge in tissue engineer-
ing (TE) and regenerative medicine is to recreate the tendon niche and replicate 
biomechanical forces involved in tendon functionality including stretching, loading, 
compression, and torsion.
One potential approach to arti!cially generating the biomechanical demands 
of tendons is using complex advanced systems such as bioreactors. Bioreactors are 
designed considering the speci!c parameters of the replacing tissue or organ, espe-
cially in what concerns to tissue biomechanics and maintenance of a desired pheno-
type prior to implantation. Since the birth of TE in the early 1990s, bioreactors have 
been primarily used for studying basic pathways, expand and grow tissue/organ sub-
stitutes, maintain ex vivo organ vitality and priming therapeutic cells before implan-
tation. The use of suitable biomechanical and biophysical environments in which 
cells could synthesize a functional matrix results in a closer mimicry of tendon 
tissue, leading to maturation of cell-laden constructs prior to implantation in vivo. 
This way, the utilization of bioreactors as in vitro models is expected to minimize 
the number of animal experiments as the implantation step only occurs when the 
morphological, biological and biomechanical properties of the engineered construct 
match those of the natural tissue.
In the tendon scenario, bioreactors have been used to culture tendon engineered 
substitutes and to investigate suitable in vitro conditions for establishing benchmarks 
and protocols for effective cell programming toward the tenogenic phenotype. Thus, 
bioreactors are promising tools for developing and culturing in vitro generated ten-
don substitutes, as potential alternatives to pharmacological therapies and to ful!ll 
the current need for tissue substitutes to treat tendinopathies.
This chapter will outline state of the art TE strategies on cell culture or cell laden 
3D matrices using mechanically active environments provided by bioreactor systems 
for tendon regeneration as a potential means to obtain functional tendon substitutes. 
For a better understanding on the performance of these systems and their role in 
strategies applied to tendon TE, the intrinsic properties and requirements of tendons 
will be explored with an emphasis on the role of biomechanical stimulation in ten-
don development and maturation, as well as the biomechanics-tissue functionality 
relationship.
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10.2  TENDON STRUCTURE-FUNCTION AND 
MECHANOBIOLOGY BEHAVIOR
10.2.1  ROLE OF MECHANICAL STIMULATION IN TENDON 
DEVELOPMENT AND FUNCTIONALITY
Tendons are specialized connective tissues that serve to transmit forces between 
muscles and bones, and thus allow body motion. Their crucial role in musculo-
skeletal functionality implies distinct mechanical properties, which are assured by 
tissue-speci!c structure and molecular composition, namely highly organized colla-
gen !bers arranged parallel to the tendon axis. The smallest structural unit of tendon 
is !bril composed of collagen molecules assembled in a quarter-staggered D-periodic 
pattern (Kastelic et al. 1978). Fibrils form !bers, which group together to form !ber 
bundles or fascicles, enveloped by thin layer of connective tissue called endotenon. 
Fascicles bundles are, in turn, enclosed by another layer of loose connective tissue 
sheath, the epitenon, that provides vasculature, lymphatics, and innervation to the 
tendon unit. Tendons may be eventually enveloped by aleoral sheath of paratenon 
that serves to reduce friction with adjacent tissues, thus enabling free tendon move-
ment against its surroundings (Kastelic et al. 1978).
Tendon !broblasts- tenocytes- are found longitudinally aligned in the rows 
between collagen !bers, and are mainly responsible for the synthesis and mainte-
nance of the extracellular matrix (ECM). Interestingly, a population of cells with 
universal stem cell characteristics, named tendon stem/progenitor cells (TSPCs), has 
been identi!ed in both human and murine tendons (Bi et al. 2007).
The major component of tendons is collagen type I that represents approxi-
mately 95% of the total collagen content and around 60% of the tissue dry mass 
(Riley et al. 1994). Tendon-speci!c mechanical integrity and function is acquired 
through a multistep process of collagen !brillogenesis during tendon development 
(Birk and Zycband 1994, Silver et al. 2003, Zhang et al. 2004). In the !rst stage, 
collagen molecules assemble in the extracellular space to form immature !bril 
intermediates. Fibril intermediates associate subsequently end-to-end forming 
longer and mechanically functional !brils. The linear growth is then followed by a 
lateral growth step, where !brils associate laterally generating fully mature !brils 
with larger diameters (Zhang et al. 2004). The process of !bril assembly is regu-
lated by heterotypic interactions between !bril-forming and !bril-associated col-
lagens, and !bril-associated proteoglycans. For example, the interaction between 
two !brillar collagen type I and type III plays a role in initial !bril assembly and 
control of !bril diameters (Banos et al. 2008). The ratio of collagen type III to col-
lagen type I exerts spatial and temporal variations throughout tendon development. 
On the other hand, in the mature tendon, collagen type III is present mainly in the 
endotenon and epitenon. Similarly, collagen type V may assemble with collagen 
type I and has been implicated in !bril nucleation and diameter regulation (Birk et 
al. 1990, Wenstrup et al. 2004). Type XII and type XIV collagens, which represent 
Fibril-Associated Collagens with Interrupted Triple-helices (FACITs), are local-
ized near the surface of !brils and may contribute to !brillogenesis regulation 
by providing molecular bridges between collagen !brils and other components of 
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the ECM. Although their role in !bril assembly is not well understood yet, it was 
hypothesized that collagen type XII may stabilize !bril structure during tendon 
development (Chiquet 1999), while type XIV limits !bril diameter (Young et al. 
2002). Beside the collagen class, molecules that belong to the family of small-
leucine-rich proteoglycans (SLRPs), such as decorin, biglycan, !bromodulin, 
and lumican, are believed to actively regulate tendon !brillogenesis, since their 
targeted disruption in mouse models lead to abnormal !bril phenotypes (Vogel 
and Heinegård 1985, Yoon and Halper 2005, Subramanian and Schilling 2015). 
Interestingly, biglycan and !bromodulin have been recognized as critical com-
ponents of tendon stem cell niche regulating TSPCs differentiation and tendon 
formation in vivo (Bi et al. 2007).
Noteworthy, the cellular composition and collagen organization are not uniform 
along the tendon length and demonstrate regional differences in the myotendinous 
junction, which is the interface between tendon and muscle and in the tendon to bone 
attachment site, called enthesis (Thomopoulos et al. 2003). These molecular and cel-
lular variations are translated in different mechanical properties of speci!c tendon 
regions that re#ect nonhomogeneous mechanical loading requirements in different 
anatomical sites (Genin et al. 2009).
The molecular mechanism governing the synthesis and spatial organization 
of collagen in developing tendons has not been fully elucidated. Since collagen 
is the main component of various connective tissues, it is impossible to trace 
tendon development by mapping its expression. In fact, no marker unique for 
tendons has been identified to date. The basic helix-loop-helix transcription 
factor scleraxis (Scx) has been described as an early tendon marker, whereas a 
type II transmembrane glycoprotein tenomodulin (Tnmd) is considered a late 
tendon marker (Shukunami et al. 2006). Though not specific to tendon, two 
other transcription factors are involved in tendon development, the homeobox 
protein Mohawk (Mkx) and a member of zinc finger transcription factor fam-
ily, early growth response factor 1 (Egr1). Mkx-null mice presented a wavy-tail 
phenotype and hypoplastic and less vibrant tendons throughout the body with 
reduced fibril diameters and down-regulation of type I collagen expression, 
when compared to the wild type (WT) counterparts. In addition to disruption 
of postnatal collagen fibrillogenesis, mutant mice exhibited abnormal tendon 
sheaths (Ito et al. 2010, Liu, Watson et al. 2010). Similarly, Egr1 has been shown 
to positively regulate collagen transcription in postnatal tendons. Egr1-/- mutant 
mice demonstrated a deficiency in expression of Scx, Col1a1 and Col1a2 genes, 
reduced fibril diameter and packing density, resulting in mechanically weaker 
tendons, compared with their WT littermates (Lejard et al. 2011, Guerquin 
et al. 2013). Interestingly, ectopic expression of either Mkx or Egr1 promoted 
tenogenic differentiation of mesenchymal stem/stromal cells (MSCs) via activa-
tion of (Transforming growth factor beta) TGF-β signaling pathway (Guerquin 
et al. 2013, Liu et al. 2014).
Tendon embryogenesis has not been fully investigated, and most of the data 
comes from developmental studies in invertebrates and chick and mouse 
models. The vertebrate tendons originate from mesoderm or mesectoderm, more 
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speci!cally, the craniofacial tendons are derived from neural crest cells, axial 
tendons originate from syndetome, whereas limb tendons come from the limb 
lateral plate. Notably, tendons share same embryological origins with cartilage 
and bone, but not with skeletal muscles, which originate from dermomyotome 
(axial), mesoderm (head), or somites (limb). Despite these distinctions, the devel-
opment of various components of the musculoskeletal system progresses in their 
close spatial and temporal association. It has been demonstrated that depending 
on the anatomic location, tendon development requires the presence of muscle. 
In chick somites, surgical ablation of dermomyotome prior to myotome forma-
tion results in the absence of Scx expression, indicating that muscle is required 
for initiation of development of axial tendons (Brent et al. 2003). Similarly, in 
Myf5-/-; MyoD-/- double-mutant embryos Scx expression is undetectable in mouse 
somites, and further supports the fact that myotome speci!cation is indispensable 
for axial tendon progenitor formation (Brent et al. 2005). Contrarily, limb and 
head tendon development are initiated independently of muscles in mouse, chick, 
and zebra!sh embryos. Scx expression is induced normally in muscleless limbs 
of Pax3 mutant mice (Schweitzer et al. 2001) and myod1-myf5 de!cient zebraf-
ish embryos, as well as in murine and zebra!sh craniofacial tendons (Berthet 
et al. 2013). However, eventually the absence of muscles results in tendon devel-
opment arrest and loss of Scx expression (Schweitzer et al. 2001, Bonnin et al. 
2005). Hence, muscle is crucial for Scx induction in axial tendons, as well as for 
the maintenance of its expression in cranial and limb tendons. Since this pattern 
has been conserved across different species, it may indicate a requirement for 
mechanical forces provided by muscle during tendon morphogenesis. The two 
main signaling pathways identi!ed as being involved in tendon development are 
TGFβ-SMAD2/3 and Fibroblast growth factor (FGF)-ERK/MAPK pathways 
(Havis et al. 2014). FGF signaling from the myotome was !rst associated with 
the induction of Scx-expressing tendon progenitors in adjacent somatic subcom-
partment of developing axial tendons in chicks (Brent et al. 2003). Disruption 
of TGFβ signaling in Tgfb2-/- and Tgfb3-/- double-mutant embryos leads to the 
loss of most tendons and ligaments (Pryce et al. 2009). Since Scx expression is 
disrupted only at E12.5, it has been suggested that TGFβ is required for tendon 
progenitor maintenance. Interestingly, in pharmacologically immobilized chick 
embryos both FGF and TGFβ signaling cascades were downregulated, suggesting 
that FGF and TGFβ ligands regulate tendon differentiation acting downstream to 
mechanical forces present in developing embryos (Havis et al. 2016). Additionally, 
growth differentiation factors (GDFs) that belong to the bone morphogenetic pro-
tein (BMP) family have been implicated in tendon development. GDF-5 de!cient 
mice exhibited altered ultrastructure and composition and inferior mechanical 
properties of Achilles tendon, when compared with control littermates (Mikic 
et al. 2001). Similarly, GDF-6 de!ciency in mice was associated with reduction 
in tail tendon collagen content and compromised tail material properties (Mikic 
et al. 2009). Beside those mentioned thus far, some other signaling pathways, such 
as the highly conserved Wnt pathway or calcium signaling might be involved in 
tendon morphogenesis.
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10.3  BIOMECHANICS IN HOMEOSTASIS AND 
TENDINOPATHIC TENDONS
Being subjected to dynamic mechanical forces in vivo, tendons exhibit a unique crimp 
pattern and viscoelastic properties akin to a spring that enable tendon to effectively 
store and subsequently release mechanical energy. In a typical tendon stress-strain 
curve, four different regions can be distinguished. The initial toe region, where ten-
don is strained up to 2%, corresponds to the stretching-out of the characteristic crimp 
pattern. In the linear region of the curve, where stretching does not exceed 4%, colla-
gen !bers lose their crimp pattern; the slope of the linear region de!nes the Young’s 
modulus (i.e., elasticity) of the tendon. Stretching over 4% results in microscopic 
tearing, whereas strain beyond 8%–10% leads to macroscopic failure and tendon 
rupture (Wang 2006). Studies of force-length relationship revealed that with increas-
ing forces, tendons lengthen to a certain degree (ascending limb)- after a certain 
point application of force results in tendon failure (descending limb) (Maganaris 
et al. 2004). Viscoelastic properties of tendon are de!ned by creep, that indicates 
increasing deformation under constant load, stress relaxation upon deformation, as 
well as hysteresis, or energy dissipation, which implies that an amount of energy is 
lost during loading. Consequently, the loading and unloading curves look differently. 
Mechanical properties vary depending on tendon anatomical site and speci!c func-
tion and are therefore dictated by the level of mechanical load to which a particular 
tendon is subjected (Bennett et al. 1986). These mechanical forces placed on tendons 
are, in turn, determined by the type of activity, passive or active mobilization, joint 
position, level of muscle contraction, tendon relative size, and so on. Additionally, 
variations in the rate and frequency of mechanical loading would result in different 
tendon forces (Wang 2006).
10.3.1 LOADING AND OVERUSE
Tendons are metabolically active tissues and tendon-resident !broblasts respond to 
dynamic mechanical loading by alterations in the synthesis of ECM components 
and matrix degrading enzymes. A growing body of evidence supports the key role 
of mechanical stress in promotion and maintenance of tendon-speci!c phenotype. 
While mechanical forces are essential for tendon development and homeostasis, both 
complete unloading and contrarily excessive loading beyond a physiological range 
might have detrimental effects on tendon functionality.
Hanna!n and colleagues investigated the effect of stress deprivation and cyclic 
tensile loading on histological and mechanical characteristics of the canine #exor 
digitorum profundus tendon (Hanna!n et al. 1995). Stress deprivation resulted in 
signi!cant changes in cell morphology and number, collagen !ber alignment, and 
progressive decrease in the tensile modulus over an eight-week period. However, ten-
dons subjected to cyclic tensile loading for 4 weeks demonstrated increased Young’s 
modulus (93% of the control) when compared to stress-deprived tendons (68% of the 
control), as well as maintained normal histological patterns (Hanna!n et al. 1995). 
Surgical release of tensile strain in an engineered human tendon model resulted in 
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disruption of tendon architecture, downregulation of tendon-related markers and 
induction of pro-in#ammatory mediators (Bayer et al. 2014). To determine if the 
loss of tensile tension could induce apoptosis in tendon cells, Egerbacher and co-
workers cultured rat tail tendons for 24 hours under cyclic loading or stress-deprived 
conditions. Upregulated caspase-3 expression and the increased number of apoptotic 
cells in stress-deprived tendons, when compared with the loaded group, indicated 
that loss of homeostatic tension induces programmed cell death (Egerbacher et al. 
2008). Employing a transgenic mouse model, where GFP expression is driven by 
the Scx promoter, Maeda and colleagues demonstrated that gradual and temporary 
loss of transmittal forces from skeletal muscles by application of botulinum toxin 
A resulting in reversible loss of Scx expression and a decline in tendon mechanical 
properties. Acute loss of tensile loading by complete tendon transection led, in turn, 
to destabilization of the ECM structure, excessive release of active TGF-β and mas-
sive tenocyte death (Maeda et al. 2011).
Wang and collaborators investigated the effect of different mechanical stimula-
tion regimes on rabbit Achilles tendon integrity in a bioreactor system (Wang et al. 
2013). In the absence of loading, gradual loss of collagen !ber organization, increased 
cellularity, and cell roundness were observed, indicating a progressive divergence 
from the native tendon phenotype. Tendons stimulated with 3% cyclic tensile strain 
demonstrated moderate ECM disruption and elevated expression levels of matrix 
metalloproteinases (MMPs), MMP-1, -3 and -12, whereas excessive loading of 9% 
resulted in partial tendon ruptures. However, tendons stimulated with 6% cyclic ten-
sile strain maintained their structural integrity and cellular function, suggesting that 
there is a narrow range of tensile loading promoting an anabolic effect and tendon 
tissue homeostasis (Wang et al. 2013). In a follow-up study, the model was extended 
to characterization of degenerative changes observed in tendons under loading-
deprived conditions. When unloaded for 6 and 12 days, tendons exhibited progres-
sive degenerative alterations, abnormal collagen type III production, increased cell 
apoptosis, and impaired mechanical properties. However, the application of a 6% 
cyclic tensile strain at day-7 for another six days was able to reverse morphological 
degenerative changes and partially restore mechanical properties of the unloaded 
tendon to the levels characteristic for the healthy tissue (Wang et al. 2015). Although 
mechanical stimulation is crucial for tendon-speci!c phenotype maintenance, exces-
sive mechanical loading has been implicated as the major causative factor of tendon 
overuse injuries, collectively referred to as tendinopathies.
Histopathological presentation of painful tendons may comprise increased 
or decreased cellularity, cell rounding, increased vascularity and innervation, 
increased collagen type III expression and proteoglycans content, and collagen !bril 
disorganization. Molecular changes in tendinopathy include elevated expression of 
collagen type I and III, biglycan, !bromodulin, aggrecan, !bronectin, tenascin C 
(TNC) and alterations in expression levels (both upregulation and downregulation) 
of MMPs, and tissue inhibitor of metalloproteinases (TIMPs) that regulate ECM 
turnover (Corps et al. 2006, Jones et al. 2006). However, the etiology of tendon 
injuries has not been fully elucidated yet, and especially the role of in#ammation 
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controversy (Riley 2008, Dakin et al. 2015, Dean et al. 2016, Millar et al. 2017, 
Fredberg and Stengaard-Pedersen 2008). Several factors have been postulated to 
be implicated in tendon disease occurrence, including age, gender, body weight, 
vascular perfusion, nutrition, joint laxity, systemic diseases, muscle weakness, 
physical load, repetitive loading, abnormal movement, poor technique and train-
ing errors, fast progression and high intensity, environmental conditions, running 
surface, and more. Moreover, genetic predisposition (e.g., variants within COL5A1, 
TNC-C, and MMP3 genes in Achilles tendinopathy), treatment with corticosteroids 
or #uoroquinolones, oral contraceptives uptake, as well as existing comorbidities, 
such as obesity, diabetes, or hyperlipidemia, have been proposed as risk factors in 
tendon pathology development (Fredberg and Stengaard-Pedersen 2008, Magra and 
Maffulli 2005, 2008, Maffulli et al. 2013).
Soslowsy and colleagues employed an intensive running regime for 4, 8, and 
16 weeks to induce an overuse injury in a rat model. Compared to the control group, 
which was allowed normal cage activity, the supraspinatus tendons in the exercised 
animals demonstrated increased cellularity and collagen !ber disorganization, the 
features that are normally observed in human tendinopathy. The tendons from the 
running group exhibited enlarged cross-sectional area and decreased mechanical 
properties, when compared to the control group (Soslowsky et al. 2000). In an in vitro 
study by Thorpe and co-workers, the application of cyclic loading mimicking high 
intensity exercise resulted in matrix damage and cell rounding in equine super!cial 
digital #exor tendon explants. Those morphological changes were accompanied by 
increased expression of in#ammatory mediators and MMPs in the loaded samples, 
when compared to the control group (Thorpe et al. 2015). Similar ECM damage and 
in#ammatory response was observed in bovine #exor tendon overloading model 
(Spiesz et al. 2015).
Due to low cellularity, poor vascularization and innervation, tendons demonstrate 
restricted intrinsic healing capacity. A repaired tendon never regains the mechanical 
properties and hence full functionality of the pre-injured tissue, indeed, !nal tensile 
strength of healed tendon might be reduced by up to 30% (Majewski et al. 2008) 
or not restored two years after surgical repair (Geremia et al. 2015). After an acute 
injury, the tendon healing process normally follows a course of distinct, overlapping 
stages of early in#ammation, proliferation, and remodeling, each orchestrated by 
a speci!c set of cellular and biochemical components. In the initial in#ammatory 
phase, erythrocytes, platelets, and in#ammatory cells (e.g., neutrophils, monocytes, 
macrophages) in!ltrate the wound site and release vasoactive and chemotactic agents 
to promote angiogenesis and !broblasts recruitment. During the proliferative phase, 
tendon !broblasts synthesize collagen and other ECM components leading to granu-
lation tissue formation around the wound site. After 6–8 weeks, !nal remodeling 
phase commences. This stage is characterized by decreasing cellularity and reor-
ganization of collagen architecture where collagen type III is replaced by collagen 
type I. As the scar matures, covalent bonding between collagen !bers increases, 
which leads to higher tendon stiffness and tensile strength. Yet, the healed tendon 
never matches characteristics of intact tissue. During tendon healing upregulation of 
several growth factors and cytokines, such as insulin-like growth factor-1 (IGF-1), 
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platelet derived growth factor (PDGF), basic !broblast growth factor (bFGF), vascu-
lar endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β), 
stimulate cell migration, proliferation, angiogenesis and synthesis of collagen and 
other ECM components (Voleti et al. 2012, Millar et al. 2017).
Tendon stem/progenitor cells role in tendon homeostasis and disease is not well 
understood yet, however it was suggested that TSPC malfunction may contribute 
to impaired healing and repair, or tendon pathology development. Especially, age-
related depletion of the stem cell pool and/or a decline in stem cell function associ-
ated with entrance of senescence state might be implicated in pathology onset and 
progression. The mechanoresponse of TSPCs have been studied both in vitro and in 
vivo indicating a critical role of mechanical loading in tendon stem cell fate and 
function. Mechanical loading at physiological level (4% stretching) promoted TSPCs 
proliferation and differentiation into tenocytes, whereas at excessive stretching (8%) 
TSPCs differentiated in non-tenocytes such as adipocytes, chondrocytes and osteo-
cytes, in addition to tenocytes (Zhang and Wang 2010a). In a follow-up in vivo study 
employing mouse treadmill running model it was found that tendons subjected to 
repetitive, strenuous mechanical loading produced high levels of PGE2, which in 
turn was associated with decreased proliferation of TSPCs and TSPC differentiation 
into adipocytes and osteocytes (Zhang and Wang 2010b). Such non-tenocyte dif-
ferentiation of TSPCs under abnormal mechanical loading may explain some patho-
logical features of late tendinopathy such as lipid accumulation, mucoid formation 
and tissue calci!cation.
Management of tendon injuries includes surgical procedures and nonsurgical 
modalities such as physiotherapy. Application of mechanical stimulation may be 
bene!cial for the proper organization of collagen !bers and prevention of adhesion 
formation during tendon healing. In injured canine #exor tendons, active mobiliza-
tion increased their tensile strength and restored gliding surfaces while reducing 
intrasynovial adhesion formation (Gelberman et al. 1986, Wada et al. 2001). In a 
rabbit model of Achilles tendon healing, early mobilization after tenotomy favored 
a more rapid restoration of tissue functionality, when compared to the group sub-
jected to continuous immobilization (Pneumaticos et al. 2000). A study of 64 human 
patients with Achilles tendon ruptures treated surgically and with early mobilization 
indicated that application of an early mobilization rehabilitation program reduces the 
range of motion loss and muscle atrophy, increases blood supply, as well as improves 
strength of calf the muscles and ankle movement (Sorrenti 2006). 12 weeks of eccen-
tric resistance training in elite soccer players increased peritendinous type I col-
lagen synthesis in individuals suffering from Achilles tendinosis, whereas collagen 
metabolism was not affected in the healthy control group (Langberg et al. 2007). 
However, a 10-year follow up study of postoperative regimes of Achilles tendon 
ruptures showed that early mobilization and immobilization in tension resulted in 
similar clinical outcomes and isokinetic strengths (Lantto et al. 2015). Although 
some con#icting data exists and the optimal rehabilitation protocol and precise 
molecular mechanism underlying the bene!cial effects of mobilization remain to be 
determined, controlled tendon-loading and motion plays crucial role in tendinopathy 
management (Rees et al. 2006).
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10.4  CURRENT THERAPIES FOR THE 
MANAGEMENT OF TENDINOPATHIES
Conservative treatments and/or grafting surgeries are the gold standards for the 
treatment of tendon injuries. The treatment of choice is in#uenced by tendon loca-
tion, type and severity of lesion as well as on the symptoms and clinical evidence 
of injury.
Independently of the treatment selected, the mid to long-term outcomes are not 
completely satisfactory with a risk of recurrence of symptoms that include pain, 
instability and degradation of mechanical function.
In the case of tissue grafting, besides the morbidity of the donor tissue and the 
risk of (re)rupture of the in#icted tendon, both tendons may experience long-term 
consequences as loss of mechanical competence, functional disability and degenera-
tion that may progress into nearby tissues.
Alternatively, tissue grafting from autologous or cadaveric sources, biological 
augmentation matrices of decellularized mammalian-origin tissues mainly human 
(GraftJacket®), porcine (Restore™), equine (OrthADAPT®) or bovine (TissueMend®) 
have been investigated and presented to the clinical !eld, revised by Chen et al (Chen 
et al. 2009). The main reasons for a lack of compliance on the medical use of these 
devices may be caused by the decellularization process that may be insuf!cient to 
remove all the resident cells and there is a potential risk of immune-rejection and for 
zoonoses transmission.
Arti!cial augmentation devices constitute an alternative to tissue grafting pro-
cedures and to biological augmentation devices (Liu et al. 2010). Commercially 
available devices as LARS™, Kennedy ligament augmentation device, Dacron®, 
Gore-Tex and Trevira, revised by Batty and colleagues (Batty et al. 2015), were 
described to avoid and provide improved knee stability (Liu et al. 2010) and full 
weight bearing. However, arti!cial devices have shown controversial outcomes on 
the long-term follow up, concerning mechanical failure or mechanical mismatch 
with native tissues, instability, synovitis, chronic effusions and progression to early 
osteoarthritis.
10.5 TENDON TISSUE ENGINEERING STRATEGIES
Tendons require a unique combination of cells within an abundant, hierarchically 
organized ECM coordinated by mechanical, biochemical, and architectural sensing 
and signaling. A failure to this balance results in signi!cant non-functional modi!-
cations and/or disease.
A traditional TE strategy is inspired by the natural elements within a tissue niche, 
namely cells, a 3D structure and their highly orchestrated biochemical signaling in 
different combinatorial approaches with the !nal goal of stimulating and inducing 
new tendon formation with restored function (Figure 10.1). As mechano-responsive 
tissues, mechanical conditioning of tendons is essential and a critical parameter of 
the native environment for tissue development and maturation, which ultimately 
will translate into successful 3D tissue equivalents and improved clinical therapies 
(Figure 10.1). 
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10.5.1 THE ROLE OF CELLS IN TENDON TISSUE ENGINEERING
Tendon resident cells, mainly tenoblasts and tenocytes, are scarce and are respon-
sible for the maintenance of ECM. These elongated cells stretched between the col-
lagen !bers of the tendon, synthesize collagen and other macromolecules, assemble 
these molecules into a cohesive unit, and organize the !ber phase in parallel with the 
direction of tensile load, which is capable of transducing and responding to mechani-
cal stimuli (Koob 2002). This organization makes it extremely dif!cult to repair 
damage to tendinous structures. Natural tendon healing usually leads to the forma-
tion of !brotic tissue, impairing tendon mechanical properties, and resulting in a 
poor quality of life. More recently, a tendon stem/progenitor cell population was 
identi!ed (Bi et al. 2007) and described to participate in the endogenous regenera-
tion process of tendons.
The hypocellular and hypovascular nature of tendons can relate to signi!cant lim-
itations in the process of repair and regeneration, especially upon tears and ruptures. 
Cells, especially the resident cell populations, have a critical role in the regulation 
of the tendon matrix in both normal and pathological conditions (Clegg et al. 2007) 



































FIGURE 10.1 Diagram on the development of a successful tissue engineered substitute 
towards clinical translation using a traditional TE approach by employing bioreactors.
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Several cell sources have been investigated for tendon strategies (Gonçalves 
et al. 2015). Tendon cells are often the !rst choice despite the donor tissue morbidity 
and the in#iction of a secondary defect to heal the damaged tendon. However, they 
are still a great source to study mechanisms and predict native biological responses. 
Other sources, such as dermal !broblasts or muscle-derived cells (Chen et al. 2016), 
have been also exploited as cell alternatives for tendon approaches.
Stem cells are also a promising source due to their high self-renewal potential 
and ability to differentiate into tissue-oriented lineages, with evidence to commit 
toward a tenogenic fate (Gonçalves et al. 2013, 2017). The secretion of a broad range 
of bioactive molecules with paracrine effects is believed to be the main mechanism 
by which MSCs achieve their therapeutic effect (Meirelles et al. 2009). The fact that 
tendons have their own local stem cell population may indicate that stem cells are 
likely to participate and even mediate the renewal and remodeling of tissues, but also 
in#uence !brous scarring due to abnormal or irregular signaling mechanisms and 
in#uence tissue recovery upon injury.
More recently, embryonic stem cells (ESCs) (Cohen et al. 2010, Chen et al. 2012) 
and induced pluripotent stem cells (iPSCs) technology (Xu et al. 2013, Bavin et al. 
2015) have also been proposed for tendon tissue engineering (TTE). Ethical con-
siderations associated with human embryos research and the risk of in vivo tera-
toma formation presents signi!cant drawbacks for the clinical application of ESCs. 
A  potential strategy to overcome many current ethical concerns in ESCs-based 
therapy is the use of iPSCs (Docheva et al. 2015), which are highly available cells 
obtained from multiple sources of autologous cells and can be reprogrammed into 
a wide range of cell types. The very few studies on human iPSCs differentiated for 
tendon applications (Xu et al. 2013, Bavin et al. 2015) show controversial outcomes 
and their potential for tendon fundamental studies and clinical approaches should be 
more deeply investigated.
Apart from cell sources, cell-based therapies offer the potential to induce a regen-
erative response by stimulating local cells and inspiring the synthesis of a structural 
matrix to ensure remodeling of damaged tendon tissues.
10.5.2 BIOACTIVE MOLECULES IN TENDON ENGINEERED SUBSTITUTES
The lack of understanding on cell-to-cell and cell-matrix communication in tendon 
niches results in limited knowledge to guide biological responses for effective treat-
ment. Moreover, cell secretome and signaling interactions are envisioned to repre-
sent the most biologically signi!cant cell role towards repair mechanisms.
Several biomolecules, some identi!ed in developmental biology studies and dis-
cussed earlier in this chapter, have been described to participate in tenogenic com-
mitment, namely EGF, FGF, PDGF, IGF-1, GDF-5, TGF-β (Gonçalves et al. 2013, 
Barsby and Guest 2013, Holladay et al. 2014, Bottagisio et al. 2017); however, their 
precise spatio-temporal distribution requires further research to promote in vitro 
tenogenic differentiation. Thus, progress towards the recognition of the molecular 
players favoring homeostasis and regeneration will assist the establishment of tendon 
benchmarks and methodologies paving the way for clinical translation of cell-based 
therapies.
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10.5.3 RECAPITULATING TENDON MATRIX IN FUNCTIONAL SUBSTITUTES
The matrix of tendon tissues is quite unique and complex: it complies with a supportive 
function of cells as its organization and structure relates to tendon mechanical proper-
ties and function adapted to the anatomical location.
Thus, another main challenge in the successful design of a tendon substitute is 
to mimic the intrinsic alignment of tendons and recapitulate their complex hierar-
chical architecture, while remaining mechanically competent towards achieving 
proper biomechanical functionality to support a complete regeneration of dam-
aged tissues.
Leading edge biomaterial advances have featured !ber fabrication technologies 
to produce architecturally aligned scaffolds aiming at tendon replacement strategies. 
These technologies include 3D-printing (Goncalves et al. 2016), a combination of 
polyelectrolyte complexation and micro#uidics (Costa-Almeida et al. 2016, Shilpa 
2017), electrospinning (Shuakat and Lin 2014, Wang et al. 2015), and an electro-
chemical alignment technique (Gurkan et al. 2010, Younesi et al. 2014) combined 
with textile techniques.
A magnetic responsive scaffold based on a polymeric blend of starch and polycap-
rolactone (PCL) !bers (SPCL) with aligned structural features incorporating mag-
netic nanoparticles by 3D-printing was shown to assist the tenogenic differentiation 
of human adipose-derived stem cells (hASCs) upon the actuation of an external 
magnetic !eld and evidenced good biocompatibility and integration within the sur-
rounding tissues upon implantation in an ectopic rat model (Goncalves et al. 2016).
Instructive tenogenic matrices with microscaled parallel aligned !brils were devel-
oped by combining polyelectrolyte complexation and micro#uidics (Costa-Almeida 
et al. 2016, Shilpa 2017). These !brous photocrosslinkable hydrogels were fabricated 
with chitosan (positively charged) and methacrylated gellan gum (negatively charged) 
(Sant et al. 2016), a combination of alginate (ALG) with methacrylated hyaluronic 
acid (MeHA, negatively charged), or chondroitin sulfate (Costa-Almeida et al. 2016). 
The MeHA-ALG !bers could be manipulated using textile technologies, allowing the 
fabrication of 3D constructs with increasing complexity and functionality.
Electrospinning is a familiar technique to TE approaches. It allows the production 
of long and continuous !bers with controlled diameter mimicking the ECM of the 
tendon at the nanoscale. Nano-scaled !bers are expected to provide topographical 
cues at the cell level and stimulate cell response by contact. Accordingly, several stud-
ies report that aligned nano!bers can stimulate different cell sources, including der-
mal !broblasts (Wang et al. 2016) and iPSCs (Zhang et al. 2015) to commit towards 
the tenogenic phenotype (Wang et al. 2016) in both synthetic and natural based scaf-
folds (Teh et al. 2013, Zhang et al. 2015, Wang et al. 2016, Sensini et al. 2017) and to 
enhance tendon regeneration in vivo (Wang et al. 2016). However, nano!ber scaffolds 
produced by electrospinning are mainly 2D systems and their scaling up into 3D 
scaffolds is limited unless combined with other scaffolding fabrication techniques 
(for instance rapid prototyping or textile approaches such as braiding and weaving).
The advancement of medical textiles has created a new generation of biomimetic 
scaffolding fabrics ranging from simple gauze or bandage materials to scaffolds for 
tissue culturing and a large variety of prostheses for permanent body implants.
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Textile technologies are powerful tools for producing complex and hierarchical 3D 
constructs using bio-inspired !ber-based materials as building blocks. Textile plat-
forms (weaving, twisting, braiding, and knitting) offer unique advantages, such as the 
versatility to !ne-tune the properties of a scaffold size, shape, porosity, and mechanical 
properties by varying the assemble parameters—namely !ber diameter, !ber number, 
or braiding angle (Czaplewski et al. 2014)—with the potential to develop improved 
3D constructs with biomimetic properties for achieving tenogenic differentiation 
(Czaplewski et al. 2014). Moreover, with textile technologies it is expected to grow 
in 3D and in a hierarchical architecture mimicking the native structure of the tendon.
A novel biofabrication modality, electrochemically aligned collagen (ELAC), 
allows the continuous production of aligned collagen threads through a pH gradient 
process between two parallel electrodes (Cheng et al. 2008) and combines textile 
techniques to fabricate complex 3D scaffolds. Since the development of this tech-
nique in 2008, several works report their potential for tendon and ligament-based 
approaches by mimicking the native tendon’s structure and mechanical properties. 
ELAC scaffolds were shown to induce MSCs tenogenic differentiation (Kishore 
et al. 2012, Younesi et al. 2014) with the production of a tenomodulin positive matrix. 
Moreover, in a rabbit patellar tendon model, ELAC braided scaffold was shown to be 
biocompatible and biodegradable and assisted the increase in volume fraction of the 
tendon fascicle compared with the control (Kishore et al. 2012).
Although these fabrication technologies assist the alignment of collagen !bers 
and mimic tendon structure, the topographical and mechanical stimulation of cells 
is still limited in these scaffolds. Thus, the application of bioreactors to culture and 
stimulate biological processes in cells laden scaffolds may more effectively recreate 
tissue dynamic environment, improving the biofunctionality of these constructs aim-
ing to mimic in vivo physiological conditions.
10.6 BIOREACTORS IN TISSUE ENGINEERING
10.6.1 DESIGNING BIOREACTORS FOR TENDON TISSUE ENGINEERING
Bioreactors have been widely investigated as advanced tools for tissue engineering 
of musculoskeletal tissues. These dynamic systems are designed to provide different 
mechanical conditioning to cells or cell laden 3D matrices in order to resemble the 
physical forces experienced in the native tissue environment, such as shear stress, 
hydrostatic pressure, #ow perfusion, microgravity or mechano-magnetic stimulation. 
For example, in bone tissues, nutrients and wastes are transported within a lacuno-
canalicular network, whose circulation has been recreated by shear stress and #ow 
perfusion systems (Rodrigues et al. 2012, Gardel et al. 2013). Bioreactors apply-
ing perfusion have also been shown to have promising results in cartilage studies 
(Rodrigues et al. 2012), as well as hydrostatic pressure bioreactors described to simu-
late the main forces to which cartilage is subjected to in the articular joints (Correia et 
al. 2012). Bioreactors offer controllable and reproducible dynamic environments with 
enhanced access of the cells to nutrient supply from the culture medium, improved 
oxygen diffusion and a more ef!cient metabolic waste removal (Table 10.1). Moreover, 
bioreactors allow homogeneous and long-term cultures with the possibility for 
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standardization and automation procedures. Depending on the system, external fac-
tors such as pH, temperature, and cell metabolite concentration can be monitored and 
adjusted, enabling higher cell proliferation rates and decreasing the number of cells 
that must be initially seeded, while favoring desirable cell responses. With the appro-
priate stimulus, it is also envisioned a reduction/elimination of medium supplementa-
tion including serum requirements. It is also expected that cultured cells subjected 
to the mechanical conditioning will be able to synthetize native tissue-like ECM in 
shorter periods of time and following a more controlled and organized distribution 
as the mechanical forces will likely better mimic the native niches. Thus, applying 
TABLE 10.1
Summary of the Main Characteristics of a Bioreactor System
Cultures in Bioreactors





• nutrient supply / waste removal
• cell metabolite quanti!cation
• Improved oxygen diffusion
• Homogeneous and long-term cultures (non-stop up to several months)
• Standardization of protocols
• Biochemical conditioning:
• Single or multi dosage without interrupting with the experimental setup
• Biomechanical conditioning:




• Closer environment to a tissue niche than static 3D cultures
Bioreactor components:
• Non-toxic, especially the parts in direct contact with the cultures
• Suitable for aseptic conditions
• Quick and easily assembled
• Sterilizable if reusable
• Preferably low-cost
• Easy to clean and store
• Portable, to !t in cell culture incubators if necessary
• Multiparameter/Tunability of parameters
• Computer control of parameters
• Real time monitoring using imaging techniques as microscopy, MRI or micro computed 
tomography
• Possibility for computer-assisted automation
• Possibility for scaling-up strategies
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bioreactors in tissue engineering strategies offers great advantages over 2D cultures 
and cell laden 3D matrices cultured in static conditions. These include (1) biome-
chanical conditioning of 3D constructs, providing adequate loading regimes accord-
ing to the type of stimulation required; (2) increase of mass transport, as the supply 
of oxygen and soluble nutrients is a critical concern when culturing 3D constructs in 
vitro; (3) controlled culture conditions enabling the systematic study of tissue-speci!c 
physiological requirements; (4) computer monitoring and programmable options to 
control and adjust environmental parameters, reducing the limitations associated to a 
human operator; and (5) reproducible cycles of stimulation/standardization. 
The development of bioengineered products is a time-consuming task and, thus, 
approaches to potentially accelerate their clinical use are needed. Bioreactor design 
can be more or less complex depending on the !nal application and monitoring 
parameters. However, all bioreactors are composed of a driving system, a control 
box and connection cables. The driving system is the motor or pump responsible for 
impelling mechanical stimulation or medium circulation through perfusion forces 
into the samples, often located in culture chambers. The control box or computer-
aided software allows controlling the system, including #uid velocity and biochemi-
cal parameters. The tubing cables, often made of materials permeable to gases, are 
necessary to connect the different parts of the bioreactor to the power socket.
Most of the bioreactors for tissue engineering settings are designed to operate 
under aseptic conditions and inside a standard CO2  incubator at 37°C. Thus, the 
assembly of the bioreactor and the positioning of the samples in the beginning of the 
experiment, as well as the handling of the system for medium exchange or collection 
of the samples for analyses are performed within biosafety hoods. The bioreactor 
materials should be non-toxic, especially the ones in contact with the constructs 
or tendon tissue samples, and bioreactor parts should be sterilizable if re-usable. 
Connecting parts such as tubes, nuts, o-rings, lids, and luer adaptors keep the system 
closed, and must be well tightened to prevent malfunctioning, #uid leakages and 
consequent contaminations. In order to assure gas interchange and pressure compen-
sation, a 0.22 μm !lter is normally used.
10.6.2 THE ROLE OF BIOREACTORS IN TENDON/LIGAMENT TISSUE ENGINEERING
The combination of multiple factors known to exist in tendon niches in a tridimensional 
and complex environment may enable the generation of predictive models relating to 
cellular responses towards scaffold design parameters and ultimately to recapitulate 
the alignment, the hierarchical architecture and tendon tissue formation. Commercial 
bioreactor systems for TTE have been designed to meet these requirements propos-
ing a solution to the limitations of static cultures. Generally, these systems allow the 
researcher to control and manipulate the deformation cycles as well as the strain and 
rate levels applied on the sample. Hereafter, we will address some of these systems with 
different complexity that may be used for biologic tendon samples or TTE constructs.
10.6.2.1 Mechanical Stimulation
The bioreactors that have been used so far for TTE greatly differ in terms of com-
plexity and multiparameter analysis (Figure 10.2). 
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One of the simplest systems is the Cell Stretching System from STREX, which 
was designed for stretching cells in culture and applying a stress load to cells up to 
20% of stretching ratio. Morita and co-workers have been working with this device to 
investigate the optimal uniaxial cyclic stretching stimulation to bone marrow MSCs 
(Morita et al. 2013, 2014, 2015, 2017) towards tenogenic differentiation. This work 
suggest optimal normal strains between 7.9% and 8.5% for assisting the production 
of Col I and TNC proteins, respectively.
Flexcell International Corporation developed Flexcell® Tension Systems, which 
are computer-regulated bioreactors that use vacuum pressure to apply cyclic or 
static strain to cells growing in vitro with control over the magnitude and fre-
quency of the stretching. Depending on the model, some systems can check and 
analyze real-time cellular biochemical changes in response to strain. In a work 
developed by Kim and colleagues (Kim et al. 2016), the FX-5000 tension system 
from Flexcell® was used to apply mechanical stress (strain of 6% elongation at a 
frequency of 1Hz) to rat periodontal ligament (PDL) cells seeded onto nano!ber-
equipped culture plates with random or aligned topography. The cells cultured 
on the oriented nano!bers combined with the mechanical stress produced PDL 
speci!c markers, including periostin and TNC, undergoing ligamentogenesis with 
simultaneous down-regulation of osteogenesis. Moreover, the cell/nano!ber con-
structs engineered under mechanical stress showed sound integration into tissue 
defects with signi!cantly enhanced new bone volume and area, in a rat premaxil-
lary periodontal defect model (Kim et al. 2016). In another recent study from Sun 
and co-workers (Sun et al. 2016), rabbit !broblasts from ligament tissues and bone 
marrow MSCs were mechanically tested under Uni#ex/Bio#ex culture system 
from Flexcell®, as a mean to mimic mechanical strain in ligament tissue. Results 
showed that uniaxial stretch (15% at 0.5 Hz; 10% at 1.0 Hz) stimulated !broblast 
proliferation and collagen production, while uniaxial strains (5%, 10%, and 15%) 
at 0.5 Hz and 10% strain at 1.0 Hz were favorable for MSCs. Similar results on the 
increment production of total collagen by human !broblasts from the rotator cuff 
with cyclic strain (Flexcell FX5K™ Tension System; 10% elongation and 0.5 Hz 
frequency) were achieved by Lohberger and colleagues (Lohberger et al. 2016). 
Also, increasing levels of the matrix metalloproteinases MMP1, MMP3, MMP13, 
and MMP14, analyzed by RT-qPCR, were observed in stimulated conditions as 
well as tenascin-C and scleraxis.
The LigaGen® Ligament and Tendon Bioreactor from BISS TGT was also 
designed to provide mechanical stimulation, imposing axial stress or strain to 3D 
tissue engineered constructs or decellularized tissues to recreate physiological con-
ditions in vitro, with studies aiming at hand tendons and anterior cruciate ligament 
(ACL) regenerative medicine. The chambers of this bioreactor deliver oscillatory 
axial stimulation to the samples. The stress/strain pro!les are de!ned by the opera-
tor, which can be in the form of a simple harmonic (sinusoidal) or a physiological 
waveform. The bioreactor can be complemented with a perfusion system to provide 
convective media transport around the samples.
The TC-3 load bioreactor from EBERS Medical Technology SL is a computer-
controlled system designed to enclose tissue samples or cell laden scaffolds under 
mechanical tension and compression axial loading.
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Herein, the tension grips apply tension loads on samples as different as sheet-like, 
membrane substrates or 3D-like samples. This speci!c bioreactor can operate in two 
different working modes, horizontal or vertical con!guration, depending on the type 
of experiment to be developed as the requirement for immersion or air liquid inter-
face, for example. TC-3 load bioreactor allows simultaneous #ow and deformation 
conditions, but hydrostatic pressure conditions can also be simulated.
ElectroForce® BioDynamic® systems from TA Instruments can be used to simu-
late in vivo conditions and provide accurate characterization of biomaterials and 
biological specimens under tension and perfusion #ow regimes. Also, an integrated 
digital video extensometer can be added to the system for primary, secondary, and 
shear strain measurements. Ligaments, tendons or other thin and elongated speci-
mens are attached to the tensile grips while the chamber is perfused with nutrients. 
The great advantage of this bioreactor in comparison to the above described is the 
possibility of integrating a Dynamic Mechanical Analysis (DMA) software, allowing 
determination of the viscoelastic properties at the same time of culture/stimulation.
Apart from the model used, the signi!cant cost of commercial bioreactors and 
the limited number of samples the operator can handle per experimental setup are 
the main disadvantages pointed out. Therefore, several research groups have custom 
designed bioreactors, developing new systems to meet more accurately the speci!c 
parameters of a tissue or tissue substitute to be screened and evaluated.
One of the most relevant parameters for tendon substitute development is the 
application of cyclic strain (Screen et al. 2005, Doroski et al. 2010, Andarawis-Puri 
et al. 2012, Legerlotz et al. 2013), and thus a major consideration to the customization 
of bioreactors.
Wang and colleagues (Wang et al. 2013) developed a bioreactor system, which 
applies pre-programmed uniaxial stimulation, to study different cyclic tensile strain 
(0.25 Hz for 8 hours/day, 0%–9% for six days) on rabbit Achilles tendons. Overall 
results showed that 3% cyclic tensile strain did not prevent matrix deterioration (gene 
expression of MMP1, 3, and 12 were highly upregulated by 3% strain stimulation 
compared to the other groups), whilst at 6% cyclic tensile strain the structural integ-
rity and cellular function of the tendons were maintained. Moreover, at 9%, massive 
rupture of the collagen bundles was also veri!ed.
Youngstrom and co-workers (Youngstrom et al. 2015) studied the in#uence of 
cyclic mechanical conditioning (0%, 3%, or 5% strain at 0.33 Hz for up to 1 hour 
daily for 11 days) provided by a custom bioreactor on the maturation and cellular 
phenotype of decellularized tendons obtained from four equine sources seeded with 
bone marrow-derived MSC. Cultured cells at 3% and 0.33 Hz integrated within these 
tissue-derived scaffolds, exhibited higher elastic modulus and higher expression of 
tenogenic genes.
10.6.2.2 Magnetic Stimulation
In recent years, magnetic driven actuation has been investigated as an alternative 
form of bio-stimulation in TE strategies. It is known that magnetic forces in#uence 
biological processes, and magnetotherapy protocols have been proposed in tissue 
regeneration and in#ammation control after injury. Furthermore, magnetic stimu-
lus may act synergistically with magnetizable nanoparticles internalized by cells in 
AQ 10
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culture or embedded within 3D scaffolds creating local forces, which can be physi-
cally sensed by cells assisting mechanotransduction processes that will ultimately 
lead to an in vitro maturation of the cell-laden constructs prior to implantation. This 
approach has been previously hypothesized and reported by our group on the use of 
magnetic bioreactors in the stimulation of stem cells towards tenogenic, osteogenic, 
or chondrogenic differentiation (Lima et al. 2015, Goncalves et al. 2016, Santos et al. 
2016) and by others for osteogenesis (Meng et al. 2013, Kang et al. 2013), cardiac 
TE (Sapir et al. 2014), and neuronal regeneration (Antman-Passig and She! 2016).
3D-printed magnetic scaffolds cultured with hASCs exposed to oscillation fre-
quency conditions provided by a magnefect-nano transfection device (nanoTherics 
Ltd, UK) showed that magnetic stimulation tend to accelerate the production of col-
lagen and noncollagenous proteins by cells after seven days (Goncalves et al. 2016). 
This device was initially set up for magnetofection purposes, but the magnetic prop-
erties of the system showed potential for applications in magnetic force-based TE.
On the other hand, magnetic responsive membranes, which were implanted sub-
cutaneously in rats exposed to a pulsed electro-magnetic !eld (PEMF) waveform 
with a magnetic !eld intensity peak of 0.01 T, a duty cycle of 6.3 ms and a frequency 
of 75 Hz for 2 hours a day, !ve days a week (Magnum XL Pro, Globus), showed to 
modulate tissue in#ammatory response, translated by a decrease in the number of 
mast cells in!ltration and reduction of the thickness of the !brous capsule (Santos 
et al. 2016). The coils that provided the mechano-magnetic stimulation within a ther-
apeutic mat were placed under the animals’ cage. Magnum devices from Globus are 
commercially available magnetotherapy devices that provide low-frequency pulsed 
magnetic !elds, being composed of solenoids that permit both the superimposition 
and the opposition of the magnetic !eld to treat surface or deep pathologies. These 
instruments are generally used in human clinical procedures, mostly physiotherapy 
centers, for applications in muscle, bone-tendon, and anti-ageing treatments. The 
use of magnetic forces in tissue healing is quite recent and some pioneer studies 
suggest the in#uence of magnetic !elds in modulating tendon injury recovery after 
rat Achilles transection (Strauch et al. 2006). Besides pain relief (Nelson eta l. 2013) 
and stimulation of blood circulation, magnetotherapy has been reported to stimulate 
tendon cell proliferation (Seeliger et al. 2014, Randelli et al. 2016) in the promotion 
of the healing process.
Bioreactors that generate PEMF have also been investigated. Recently, Liu and 
colleagues (Liu et al. 2016) and Tucker and colleagues (Tucker et al. 2017) described 
the use of a commercial device, Physio-Stim® PEMF system from Ortho!x Inc, to 
promote gene expression of human tenocytes (collagen I, TGFβ-1, PDGFβ, BMP12, 
and TIMP4) and to improve early tendon healing in a rat rotator cuff model, respec-
tively. The FDA approved Ortho!x stimulators claim to generate a uniform, low-
level PEMF shown to be safe in clinical studies for the healing of nonunion fractures 
(Garland et al. 1991).
The portable SomaPulse® is another non-invasive PEMF system. It applies a 
sequence of magnetic pulses programmed to introduce a magnetic !eld into mus-
culoskeletal tissues. Despite the multiple devices available for magnetic stimulation, 
the application of electromagnetic !elds is still not properly understood, nor how 
the exposure to PEMF in#uences tendon resident cells or tendon tissue responses. 
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Despite the recent scienti!c interest on the magnetic force impact over biological 
tissues, the wide range of magnetic properties, such as intensity, time of exposure or 
frequency, has to be more deeply explored and optimized to individual conditions, 
tendon anatomical location, and associated pathologies. Electromagnetic !elds are 
expected to in#uence cells response at the molecular levels or to act as mediators 
of in#ammation. Girolamo and co-workers (Girolamo et al. 2013) reported that a 
PEMF (1.5mT, 75 Hz) enhanced tendon cell proliferation and the release of anti-
in#ammatory cytokines and angiogenic factors (IL-1B, IL-6, IL-8, and TGF-β). 
Herein, the PEMF was generated by a pair of rectangular horizontal coils placed 
opposite to each other.
10.7 MECHANOREGULATION MECHANISMS
Physiological responses to mechanical loading are initiated by a process called 
mechanotransduction, in which cells detect physical changes in their microenvi-
ronment through specialized machinery and then translate that information into an 
appropriate biological response (Santos et al. 2015). This mechanosensitive feedback 
mechanism modulates cellular functions as proliferation, differentiation, migration, 
and apoptosis, and is crucial for organ development and homeostasis (DuFort et al. 
2011).
Tendon tissues, physiologically adapted to transmit mechanical forces in a daily 
basis, are the perfect model to study the mechanisms involved in the translation of 
mechanical forces into a functional response.
Growing evidence suggests that mechanical forces regulate the expression of the 
bHLH transcription factor Scx through activation of the TGF-β/Smad2/3 pathway 
in adult tenocyte cultures, which, in turn, is required for maintenance of tendon-
speci!c ECM (Maeda et al. 2011, Havis et al. 2016, Gaut and Duprez 2016).
Furthermore, it is accepted that these forces can be at least partially mimicked by 
the stimuli provided by bioreactors.
Mohawk (Mkx) and the downstream tendon-associated genes Tenomodulin 
(Tnmd), Collagen type I (Col1a1 and Col1a2), but not Scleraxis (Scx), showed an 
increased expression in Achilles tendon-derived rat tenocytes subjected to stretching 
at 2% and 0.25 Hz for 6 hours in a FX-5000 tension system (Flexcell International) 
(Kayama et al. 2016).
Moreover, magnetic-mechano actuation directed to cell surface receptors is a 
good example to remotely deliver mechanical stimuli into individual cells. Studies 
reported that a magnetic !eld of variable frequency may in#uence cellular response 
and intracellular signaling favoring the differentiation into desired phenotypes and 
higher proliferation rates in a shorter culture time and in a more reproducible man-
ner (Girolamo et al. 2013, Henstock et al. 2014, Rotherham and El Haj 2015, Sapir-
Lekhovitser et al. 2016).
3D scaffolds may also be used for tendon mechanobiology studies, in which the 
actuation of mechanical loads provided by bioreactors may be combined with the 
stimulation from the topographical and physicochemical properties of the scaffold to 
the seeded cells. An example is the !ber composite hydrogels developed by Screen 
and co-workers (Screen et al. 2010) who envisioned to be a mechanotransduction 
AQ 11
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research platform. Collagen type I gene expression was upregulated in NIH/3T3 !bro-
blasts laden in the hydrogels and subjected to cyclic tensile loading of 5% dynamic 
tensile strain, at 1 Hz for 24 hours.
Also, Jones and colleagues (Jones et al. 2013) showed that TGFβ activation plays 
an important role in mechanotransduction, speci!cally in the regulation of MMP 
genes of human tenocytes isolated from tissues with tendinopathic conditions. These 
tenocytes were seeded onto 3D collagen gels and a 5% cyclic uniaxial strain at 1 Hz 
for 48 hours was applied over these constructs using the Flexcell FX-4000™ device. 
Treatments with TGFβ1/TGFβRI inhibitor were compared to mechanical strain 
regimes, and the outcomes with strain or TGFβ treatment were similar. Overall, 
there was a decrease in MMP1, -3, -11, -13, and -17 and an increase in collagen type 
I at the mRNA level (Jones et al. 2013).
10.8 CONCLUDING REMARKS
Since the !rst investigation of tendon/ligament bioreactors published in the 1990s 
(Hanna!n et al. 1995), these devices have evolved into more complex systems able to 
test more specimens simultaneously and control/program several parameters. Despite 
the advances in recent years and the awareness for mimicking the different fundamen-
tal aspects of tendons, which are intrinsically associated to tissue function and activity, 
currently available tendon substitutes are not biomechanically competent as arti!cial 
replacements of tendons. Nevertheless, bioreactors can ful!ll this functional gap offer-
ing a powerful solution for improving and assisting the development of new tissue engi-
neering equivalents as they provide a controlled, dynamic and monitorable environment 
that more closely resembles native tissues, with potential toward scale up strategies.
Moreover, bioreactors provide the possibility for testing a variety of different cell 
laden 3D structures, including scaffolds, membranes, tissue explants, and more, that 
can be investigated and assessed in systematic and reproducible conditions as pre-
dictive tools of tissue substitute performance in similar physiological conditions, 
resembling the native environment. However, the optimal in vitro conditions and the 
optimal 3D tissue substitute have not been established, and the challenge stands for 
an accurate time spatial recapitulation of physical and biochemical signals that cells 
may experience in tendon niches, as well as cell response to such potential stimuli, 
providing important insights into the long-term capability of engineered constructs 
to maintain tissue proper functionality. Cellular mechano-sensing mechanisms and 
the information exchange in biomechanical regulatory signals between the cell and 
its surroundings also have an important role in determining the potential outcomes 
of bioreactor microenvironments towards pre-clinical models. These issues need to 
be thoroughly addressed in forthcoming years in order to achieve bioreactor designs 
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BGN Byglican
BMP Bone morphogenetic protein
Col I Collagen type I
DCN Decorin
DMA Dynamic Mechanical Analysis
ECM Extracellular matrix
EGF Epidermal growth factor
ELAC Electrochemically aligned collagen
FACITs Fibril-Associated Collagens with Interrupted Triple-helices
FGF Fibroblast growth factor
GDF-5 Growth and differentiation factor 5
hASCs Human adipose-derived stem cells
Hz Hertz
IGF-1 Insulin-like growth factor 1
MRI Magnetic resonance imaging




PDGF Platelet-derived growth factor
PDL Periodontal ligament
PEMF Pulsed Electromagnetic Fields
SPCL Starch poly(ε-caprolactone)
TE Tissue engineering
TIMP Tissue inhibitor of metalloproteinases
TSPCs Tendon stem/progenitor cells
TTE Tendon Tissue Engineering
TNC Tenascin
TGF-β Transforming growth factor beta
Scx Scleraxis
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